4.7 Article

Development of cerium and silicon co-doped hydroxyapatite nanopowder and its in vitro biological studies for bone regeneration applications

Journal

ADVANCED POWDER TECHNOLOGY
Volume 29, Issue 11, Pages 2792-2803

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.apt.2018.07.028

Keywords

Ce-HAP; Ce/Si-HAP; Erythrocytes; Bioactivity; MG-63 Osteoblast

Funding

  1. DST-SERB, India [SB/FT/CS-091/2012]

Ask authors/readers for more resources

Multi-ion, co-substituted bioactive glass ceramics play a significant role in the stimulation of physical and biological properties for outstanding effects in biomedical application. The following work attempts to develop HAP as a parent material doped with a combination of cerium (Ce4+ @1.25 wt%) and silicon (Si4+ @1, 3 and 5 wt%) by refluxing based sol-gel technique. The anti-bacterial tests exhibit E. coli showing higher inhibition efficiency, in vitro hemolytic test exhibit good compatible nature of dual doped HAP with erythrocytes (<5% of hemolytic). In vitro bioactivity assay confirms that the developed dual doped HAP possesses excellent bone-like apatite layer formation on their surfaces. In vitro cellular study was performed for Ce/Si-HAP@5% powder against MG-63 cells, which demonstrated the good cell viability at higher concentrations (up to 800 mu g/ml). Further, dual doped HAP powders were characterized by various analytical techniques such as ATR-FTIR, Powder-XRD, TGA-DTA, SEM-EDS, TEM and XPS analysis. The studies confirm that the synthesized dual doped HAP will act as better bioactive glass ceramics for potential orthopedic and dentistry applications. (C) 2018 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available